PRWeb ebooks - Another online visibility tool from PRWeb
The American College of Medical Toxicology will present a webinar on the treatment of opioid
dependent patients. The webinar, which is available to health care providers, health
administrators, and epidemiologists, will take place on October 15, 2012.
Phoenix, Arizona (PRWEB) October 15, 2012 -- Epidemic increases in prescription drug abuse, primarily
involving the abuse of opioid analgesics, have fueled dramatic increases in opioid addiction and dependence.
Chronic pain has reached epidemic levels and the use of long-term, high-dose opioid therapy has increased
concomitantly. Although it was previously believed that patients given short-term opioids for relief of acute
pain, such as following surgery, were at very low risk of addiction, more recent data suggests that this is not
correct. Several studies have documented that 3-7% of patients who received opioid analgesic prescriptions
following minor operative procedures were still using these potent medications weeks or months later. In
addition, a recent report of 2011 data from the American College of Medical Toxicology’s (ACMT) Toxicology
Investigators Consortium (ToxIC) Registry, published in the Journal of Medical Toxicology, also found that
opioid pain relievers were among the most common medications accounting for poisoning cases managed by
medical toxicologists, and were the most common cause of death reported in the registry.
Local and state medical societies as well as state medical boards have called for increased education related to
the prevention and treatment of addictive disorders, in particular from opioid analgesics. Education is one part
of a four-pronged approach described in “Epidemic: Responding to America's Prescription Drug Abuse Crisis”,
released in 2011 by the White House Office of National Drug Control Policy. As part of a continued effort to
educate health care professionals about treatment options for opioid dependence, ACMT will host an
educational webinar entitled “Medication Assisted Treatment for Opioid-Dependent Patients –Getting Started
as a Provider.” This 75 minute interactive webinar will be presented by Dr. Norm Wetterau, President of the
New York Society of Addiction Medicine and Dr. Timothy Wiegand, Director of Toxicology at the University
of Rochester Medical Center and Medical Director of Huther-Doyle Chemical Dependency Program in
Rochester, New York.
The webinar will describe how to establish a medication assisted treatment (MAT) program for opioid
dependent patients as well as review the role of the opioid agonist buprenorphine (SuboxoneTM). Dr. Wetterau
and Dr. Wiegand will describe the certification process for obtaining the special DEA X license, which is
required for the prescription of buprenorphine for the treatment of opioid dependence, and review medication
assisted treatment options including alternatives to opioid agonists. Monitoring and referral requirements as
well as resources and support for office-based opioid treatment (OBOT) providers will also be covered and a
description of different models including office-based and chemical dependency (or ‘detoxification’) programs
for the outpatient treatment of opioid dependence will be provided.
The ACMT has no role in the certification of buprenorphine providers and no relationship, financial or
otherwise, with the sponsor of the medication. The ACMT is a professional, nonprofit association of physicians
with recognized expertise in medical toxicology. The College is dedicated to advancing the science and practice
of medical toxicology.
If you have any questions regarding information in these press releases please contact the company listed in the press release. Our complete disclaimer
appears here - PRWeb ebooks - Another online visibility tool from PRWeb
American College of Medical Toxicology
Online Web 2.0 Version
You can read the online version of this press release here.